文献速递免疫规划卫生政策与健康促进

高剂量与标准剂量流感疫苗在美国退伍军人中的经济学评估:对心肺疾病住院费用的影响

Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
PubMed 文献 · Vaccine · 2019-06-28

该研究基于2010/11至2014/15五个呼吸道季节的相对疫苗效果数据,比较高剂量三价(HD)与标准剂量三价(SD)流感疫苗在65岁及以上美国退伍军人健康管理局(VHA)人群中对心肺疾病住院直接医疗费用的经济影响。结论认为HD流感疫苗接种与净费用节省相关。

要点

  • HD疫苗每接种者平均费用23.48美元,SD为12.21美元。
  • HD组心肺疾病住院率为0.114/人-季节,SD组为0.132/人-季节。
  • 归因于住院率差异,HD疫苗每接种者净节省202美元(95%CI:115-280)。

核心结论

  • 在2010/11至2014/15五个季节中,HD流感疫苗接种与因心肺疾病住院减少而带来的净费用节省相关,相比SD疫苗降低了直接医疗费用。

研究设计与样本

  • 基于HD与SD疫苗相对疫苗效果研究的经济评估,覆盖五个呼吸道季节(2010/11至2014/15),收集VHA和Medicare服务的成本数据,比较疫苗接种和心肺疾病住院费用。
  • 分析纳入3.5百万SD和158,636 HD人-季节,对象为65岁及以上VHA参保成人。

主要发现

  • HD和SD疫苗接种平均费用分别为每接种者23.48美元(95%CI:21.29-25.85)和12.21美元(95%CI:11.49-13.00)。
  • HD和SD组心肺疾病住院率分别为0.114(95%CI:0.108-0.121)和0.132(95%CI:0.132-0.133)每人-季节。
  • 平均每次住院费用为11,796美元(95%CI:11,685-11,907),归因于住院率差异,HD疫苗每接种者估计节省202美元(95%CI:115-280)。

临床怎么用

  • 对于65岁及以上VHA人群,选择HD流感疫苗可能通过减少心肺疾病住院而节省净费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the economic impact of high-dose trivalent (HD) versus standard-dose trivalent (SD) influenza vaccination on direct medical costs for cardio-respiratory hospitalizations in adults aged 65 years or older enrolled in the United States (US) Veteran's Health Administration (VHA). METHODS: Leveraging a relative vaccine effectiveness study of HD versus SD over five respiratory seasons (2010/11 through 2014/15), we collected cost data for healthcare provided to the same study population both at VHA and through Medicare services. Our economic assessment compared the costs of vaccination and hospital care for patients experiencing acute cardio-vascular or respiratory illness. RESULTS: We analyzed 3.5 million SD and 158,636 HD person-seasons. The average cost of HD and SD vaccination was $23.48 (95% CI: $21.29 - $25.85) and $12.21 (95% CI: $11.49 - $13.00) per recipient, respectively, while the hospitalization rates for cardio-respiratory disease in HD and SD recipients were 0.114 (95% CI: 0.108-0.121) and 0.132 (95% CI: 0.132-0.133) per person-season, respectively. Attributing the average cost per hospitalization of $11,796 (95% CI: $11,685 - $11,907) to the difference in hospitalization rates, we estimated savings attributable to HD to be $202 (95% CI: $115 - $280) per vaccinated recipient. CONCLUSIONS: For the five-season period of 2010/11 through 2014/15, HD influenza vaccination was associated with net cost savings due to fewer hospitalizations, and therefore lower direct medical costs, for cardio-respiratory disease as compared to SD influenza vaccination in the senior US VHA population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. van Aalst R, Russo EM, Neupane N, et al. Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease. Vaccine. 2019. PMID: 31262590. doi:10.1016/j.vaccine.2019.06.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。